NASDAQ:MGX

Metagenomi Therapeutics, Inc.

Company facts

Most recent report
8-K, filed Sep 22, 2026
Filings on record
154 filings
On EDGAR
CIK 1785279
Fiscal year ends
December
Filer status
Emerging growth company

Financials 8 of 11

News 8 of 23

Prospectuses and Registrations 8 of 9

Proxies 4

Ownership 8 of 78

Other 8 of 29

Everything here comes from Metagenomi Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.